$3.27
-0.13-3.96%
At close: -
$3.16
-0.11-3.36%
After Hours: 7:31 PM EDT
Qualigen Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Qualigen Therapeutics using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2024-04-08 | $-23.50 | $-26.00 | 9.62 % |
Q3 | 2023-11-14 | $-32.00 | $-46.00 | 30.4 % |
Q2 | 2023-08-15 | $-34.50 | $-26.00 | -32.7 % |
Q3 | 2022-11-15 | $-50.00 | $-65.00 | 23.1 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2023-11-14 | $0 | $500.00K | -100.0 % |
Q2 | 2023-08-15 | $1.63M | $1.60M | 1.69 % |
Q1 | 2023-05-16 | $1.61M | $2.00M | -19.6 % |
Q3 | 2022-11-15 | $1.44M | $1.62M | -11.1 % |
Qualigen Therapeutics (QLGN) is scheduled to report earnings on April 7, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-4.70, which missed the estimate of $0.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.